FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

209011000036103: injection solution dose form (AU qualifier)

    Status: retired, Primitive. Date: 30-Nov 2018. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    170651011000036116 injection solution dose form (AU qualifier) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    170652011000036110 injection solution en Synonym Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    injection solution Is a injection false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Grandicrit 7000 units/0.7 mL injection, 0.7 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 1000 units/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit (epoetin lambda 5000 international units / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 8000 units/0.8 mL injection, 0.8 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 3000 units/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 6000 units/0.6 mL injection, 0.6 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 9000 units/0.9 mL injection, 0.9 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 10 000 units/mL injection, syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 8000 units/0.8 mL injection, 0.8 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit (epoetin lambda 4000 international units / 0.4 mL) injection, 0.4 mL syringe (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 1000 units/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 10 000 units/mL injection, syringe has manufactured dose form False injection solution Inferred relationship Some
    Myocrisin 20 mg/0.5 mL injection, 0.5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Myocrisin 10 mg/0.5 mL injection, 0.5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Myocrisin 50 mg/0.5 mL injection, 0.5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 4000 units/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Kineret 100 mg/0.67 mL injection, 0.67 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Grandicrit 3000 units/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Simponi 50 mg/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Simponi SmartJect 50 mg/0.5 mL injection: solution, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 9000 units/0.9 mL injection, 0.9 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Naglazyme 5 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 2000 units/mL injection, syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 60 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Ephedrine Sulfate (DBL) 30 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 6000 units/0.6 mL injection, 0.6 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 20 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Novicrit 7000 units/0.7 mL injection, 0.7 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 60 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 80 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 100 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 50 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 150 microgram/0.3 mL injection solution, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick (darbepoetin alfa 100 microgram / 0.5 mL) injection solution, 0.5 mL syringe (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 20 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 60 microgram/0.3 mL injection solution, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 150 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 40 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 (iomeprol 714.4 mg / 1 mL) injection, 75 mL vial (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 10 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 714.4 mg (iodine 350 mg)/mL injection, 250 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 80 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 714.4 mg (iodine 350 mg)/mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 40 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 (iomeprol 714.4 mg / 1 mL) injection, 50 mL vial (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 20 microgram/0.5 mL injection solution, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 714.4 mg (iodine 350 mg)/mL injection, 200 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 150 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-350 (iomeprol 714.4 mg / 1 mL) injection, 20 mL vial (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 80 microgram/0.4 mL injection solution, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 75 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 100 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 30 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 20 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 40 microgram/0.4 mL injection solution, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Sodium Bicarbonate Min-I-Jet (CSL) 4.2 g/50 mL injection, 50 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 50 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 30 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Iomeron-300 612.4 mg (iodine 300 mg)/mL injection, 200 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 150 microgram/0.3 mL injection, 0.3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Sodium Bicarbonate (Phebra) 8.4% (840 mg/10 mL) injection, 10 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 50 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Firazyr 30 mg/3 mL injection, 3 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Elonva 150 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Arixtra 2.5 mg/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Elonva 100 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Haemorol 250 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Haemorol Oily Phenol (Phebra) 250 mg/5 mL injection, 5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Tracrium 50 mg/5 mL injection, 5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Atracurium Besylate (Abbott) (atracurium besilate 25 mg / 2.5 mL) injection, 2.5 mL ampoule (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Atracurium Besylate (Abbott) 50 mg/5 mL injection, 5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Betaloc 5 mg/5 mL injection, 5 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Ebewe) 100 mg/50 mL injection, 50 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Actavis) 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Pharmorubicin 200 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Ebewe) 10 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Actavis) 20 mg/10 mL injection, 10 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Actavis) 100 mg/50 mL injection, 50 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Novotech) 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Pharmorubicin 10 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (DBL) 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (DBL) 100 mg/50 mL injection, 50 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Deltazine 1 in 100 000 injection, 2.2 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Deltazine 1 in 100 000 (articaine hydrochloride 68 mg / 1.7 mL + epinephrine 17 microgram / 1.7 mL) injection, 1.7 mL cartridge (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Bucanest 4% / 1 in 100 000 injection, 1.7 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Pharmorubicin 20 mg/10 mL injection, 10 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Bucanest 4% / 1 in 100 000 injection, 2.2 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Septanest 1 in 100 000 injection, 2.2 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Actavis) 10 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Septanest 1 in 100 000 injection, 1.7 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Novotech) 200 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Kabi) 200 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Ebewe) 200 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Pharmorubicin 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Novotech) 20 mg/10 mL injection, 10 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Mayne Pharma) 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (DBL) 200 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Novotech) 10 mg/5 mL injection, 5 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Epirubicin Hydrochloride (Kabi) 50 mg/25 mL injection, 25 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Clopixol Acuphase 100 mg/2 mL injection, 2 mL ampoule has manufactured dose form False injection solution Inferred relationship Some

    Start Page 2 of 18 Next End

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start